Paul Tudor Jones’s Idexx Laboratories IDXX Stock Holding History

Paul Tudor Jones’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,342	Closed	-$4.69M	–	3894
2026 Q1	$4.69M	Buy	+8,342	New	+$5.35M	0.01%	1209
2025 Q4	–	Sell	-6,614	Closed	-$4.5M	–	3728
2025 Q3	$4.23M	Sell	6,614 -11,313	-63%	-$6.87M	0.01%	1295
2025 Q2	$9.61M	Sell	17,927 -20,125	-53%	-$9.62M	0.02%	685
2025 Q1	$16M	Buy	38,052 +36,086	+1,836%	+$15.7M	0.05%	278
2024 Q4	$813K	Buy	+1,966	New	+$862K	﹤0.01%	1876
2024 Q3	–	Sell	-1,280	Closed	-$622K	–	2897
2024 Q2	$624K	Buy	+1,280	New	+$643K	﹤0.01%	1706
2023 Q4	–	Sell	-2,402	Closed	-$1.05M	–	2592
2023 Q3	$1.05M	Sell	2,402 -10,991	-82%	-$5.48M	0.01%	1273
2023 Q2	$6.73M	Buy	+13,393	New	+$6.42M	0.08%	308
2023 Q1	–	Sell	-11,982	Closed	-$5.73M	–	2669
2022 Q4	$4.89M	Buy	11,982 +7,750	+183%	+$3.01M	0.1%	261
2022 Q3	$1.38M	Sell	4,232 -7,387	-64%	-$2.71M	0.03%	722
2022 Q2	$4.08M	Buy	+11,619	New	+$4.74M	0.11%	232
2021 Q4	–	Sell	-5,911	Closed	-$3.71M	–	2689
2021 Q3	$3.68M	Buy	+5,911	New	+$3.97M	0.06%	390
2021 Q2	–	Sell	-6,549	Closed	-$3.2M	–	1738
2021 Q1	$3.2M	Sell	6,549 -4,155	-39%	-$2.08M	0.06%	330
2020 Q4	$5.35M	Buy	10,704 +4,138	+63%	+$1.85M	0.15%	123
2020 Q3	$2.58M	Buy	6,566 +3,103	+90%	+$1.15M	0.11%	210
2020 Q2	$1.14M	Sell	3,463 -1,328	-28%	-$385K	0.06%	436
2020 Q1	$1.16M	Buy	+4,791	New	+$1.25M	0.1%	210
2018 Q4	–	Sell	-3,032	Closed	-$757K	–	1117
2018 Q3	$757K	Sell	3,032 -780	-20%	-$189K	0.02%	550
2018 Q2	$831K	Buy	3,812 +2,405	+171%	+$496K	0.03%	500
2018 Q1	$269K	Sell	1,407 -3,117	-69%	-$575K	0.01%	779
2017 Q4	$707K	Buy	+4,524	New	+$712K	0.02%	466
2016 Q4	–	Sell	-4,599	Closed	-$518K	–	1502
2016 Q3	$518K	Sell	4,599 -1,113	-19%	-$117K	0.01%	717
2016 Q2	$530K	Buy	+5,712	New	+$491K	0.01%	798
2015 Q4	–	Sell	-10,711	Closed	-$795K	–	1736
2015 Q3	$795K	Sell	10,711 -19	-0.2%	-$1.36K	0.03%	495
2015 Q2	$688K	Buy	+10,730	New	+$743K	0.02%	602
2015 Q1	–	Sell	-4,400	Closed	-$326K	–	1519
2014 Q4	$326K	Sell	4,400 -16,682	-79%	-$1.17M	0.01%	995
2014 Q3	$1.24M	Buy	21,082 +17,882	+559%	+$1.13M	0.04%	218
2014 Q2	$214K	Buy	+3,200	New	+$203K	0.01%	1009
2014 Q1	–	Sell	-4,814	Closed	-$256K	–	1301
2013 Q4	$256K	Buy	+4,814	New	+$253K	0.01%	976
2013 Q3	–	Sell	-6,000	Closed	-$269K	–	878
2013 Q2	$269K	Buy	+6,000	New	+$262K	0.02%	608

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Paul Tudor Jones's IDXX Position: Q2 2026 in Review

Paul Tudor Jones sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 8,342 shares — an estimated $4.69M sold.

Paul Tudor Jones first reported a position in IDXX in Q2 2013 and held it in 30 quarters. The position peaked at $16M in Q1 2025. 1,293 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Paul Tudor Jones reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
Paul Tudor Jones sold 8,342 Idexx Laboratories shares in Q2 2026, an estimated $4.69M.
Paul Tudor Jones first reported a position in Idexx Laboratories in Q2 2013 and held it in 30 quarters.
Paul Tudor Jones's Idexx Laboratories position peaked at $16M in Q1 2025.
1,293 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.